Is there a Teriparatide shortage in 2026? Get the latest update on Forteo and generic teriparatide availability, pricing, and what to do if you can't find your medication.
If you've been trying to fill a prescription for Teriparatide (Forteo) and running into dead ends, you're probably wondering: is there a shortage? The answer is nuanced — and understanding what's actually going on can help you take the right steps to get your medication.
Here's the full picture on Teriparatide availability in 2026.
As of early 2026, Teriparatide is not listed on the FDA or ASHP drug shortage databases. That means there isn't an official, industry-wide shortage of the medication. Both brand-name Forteo (manufactured by Eli Lilly) and generic teriparatide (from Teva and other manufacturers) are being produced and distributed.
However, "not in shortage" doesn't always mean "easy to find." Many patients still report difficulty locating Teriparatide at their local pharmacies. The reasons have more to do with how this medication is distributed than with supply problems.
Even without an official shortage, several factors make Teriparatide difficult to access:
Teriparatide is a specialty medication that requires refrigeration. Most retail pharmacies don't keep it on hand. Instead, it's typically dispensed through specialty pharmacies that have the infrastructure for cold chain storage and shipping.
Prior authorization is required by most insurance plans, including Medicare Part D. Many plans also enforce step therapy, requiring documented failure of cheaper bisphosphonates before they'll cover Teriparatide. These requirements can delay access by days or weeks.
In early 2025, Eli Lilly updated the labeling and metric quantities on Forteo pens. While the medication itself didn't change, the updated National Drug Code (NDC) numbers and package descriptions caused temporary billing issues at pharmacies. Some of these administrative ripple effects have lingered into 2026.
At a cash price of $3,100–$5,400 per pen for brand-name Forteo, some pharmacies are reluctant to stock it without a confirmed prescription and payment — they don't want expensive inventory sitting on shelves.
Here's a breakdown of current pricing for a single pen (28-day supply):
If you're uninsured, the Lilly Cares Foundation Patient Assistance Program may provide Forteo at no cost. See our full savings guide for details.
The osteoporosis treatment landscape has expanded significantly. If Teriparatide isn't accessible for you, there are alternatives worth discussing with your doctor:
Read more in our full guide to Teriparatide alternatives.
If you need Teriparatide now, here's what to do:
For a step-by-step walkthrough, see our guide on how to find Teriparatide in stock near you.
There's no official Teriparatide shortage in 2026, but real-world access barriers — specialty distribution, insurance hoops, and high costs — mean plenty of patients still struggle to get it. The key is to be proactive: use tools like Medfinder, explore both brand and generic options, and work closely with your healthcare team to navigate prior authorization and find the best path to your medication.
Your bones can't wait — and neither should you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
